Abstract

Ischemic stroke is a condition resulting from a lack of blood flow to the brain. One of the therapies used for ischemic stroke is antiplatelet. Single antiplatelet therapy is generally preferred over combination antiplatelet therapy, because combination therapy results in increased bleeding, which outweighs any benefits. Various studies on the effectiveness of antiplatelet between the combination of aspirin and clopidogrel with aspirin in ischemic stroke patients have been carried out. However, until now there is no consensus that the outcome is better between single aspirin therapy with the aspirin-clopidogrel combination. The aim of this study was to compare the effectiveness of the combination aspirin-clopidogrel and aspirin in ischemic stroke. The method used in this study is a literature review using Google Scholar, PubMed, and Science Direct databases. From the 5 literature that has been reviewed, it shows that in patients with minor ischemic stroke the combination of aspirin-clopidogrel is more effective than single aspirin which is seen from several parameters including Modified Rankin Scale (mRS), European Quality of Life – 5 Dimension (EQ-5D), National Institute of Health Stroke Scale (NIHSS), Activated Partial Thromboplastin Time (aPTT), leukocyte platelet aggregation and leukocyte-platelet aggregate.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call